ST14 Antikörper (AA 11-100)
-
- Target Alle ST14 Antikörper anzeigen
- ST14 (Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14))
-
Bindungsspezifität
- AA 11-100
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser ST14 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))
- Kreuzreaktivität
- Human
- Homologie
- Mouse,Rat
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human Matriptase
- Isotyp
- IgG
-
anti-Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14) (AA 826-855), (C-Term) antibody
ST14 Reaktivität: Human, Maus WB, IHC (p) Wirt: Kaninchen Polyclonal RB2080 unconjugated
anti-Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14) (Internal Region) antibodyST14 Reaktivität: Human, Maus WB, ELISA, IHC, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14) antibodyST14 Reaktivität: Human, Maus, Ratte WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14) (C-Term) antibodyST14 Reaktivität: Human, Maus, Ratte, Rind (Kuh), Meerschweinchen, Pferd, Schwein, Kaninchen, Hund WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14) (N-Term) antibodyST14 Reaktivität: Human WB, IF, IHC (p), EIA Wirt: Kaninchen Polyclonal unconjugated
anti-Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14) antibodyST14 Reaktivität: Human, Maus ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14) (AA 298-400) antibodyST14 Reaktivität: Human ELISA Wirt: Maus Monoclonal 2F4 unconjugated
anti-Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14) (AA 10-59) antibodyST14 Reaktivität: Human WB, ELISA, IHC, IF, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14) (N-Term) antibodyST14 Reaktivität: Human WB, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14) (AA 566-855) antibodyST14 Reaktivität: Human ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- Haltbarkeit
- 12 months
-
- Target
- ST14 (Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14))
- Andere Bezeichnung
- Matriptase (ST14 Produkte)
- Hintergrund
-
Synonyms: HAI, MTSP1, SNC19, ARCI11, MT-SP1, PRSS14, TADG15, TMPRSS14, Suppressor of tumorigenicity 14 protein, Matriptase, Membrane-type serine protease 1, Prostamin, Serine protease 14, Serine protease TADG-15, Tumor-associated differentially-expressed gene 15 protein, ST14
Background: Degrades extracellular matrix. Proposed to play a role in breast cancer invasion and metastasis. Exhibits trypsin-like activity as defined by cleavage of synthetic substrates with Arg or Lys as the P1 site. Involved in the terminal differentiation of keratinocytes through prostasin (PRSS8) activation and filaggrin (FLG) processing.
- Gen-ID
- 6768
- UniProt
- Q9Y5Y6
-
